Significant interest rate hikes in the U.S. board and executive sector will continue until 2021, as insurance results decline despite record growth, Fitch Ratings Inc. said in a report on Wednesday.
D&O premiums increased by 40% in 2020 and by 20% in 2019, but insurance losses are expected to continue in the short term, Fitch said.
After several years of flat to declining revenue growth, D&O increased direct depreciation premium volume to $ 10.7 billion by 2020, the Report said.
A 67% cumulative increase in market premiums over the last two years has not led to a turnaround in insurance results in D&O.
"The market has been disrupted by a confluence of challenging economic, regulatory, legal, investment and social factors since the start of the pandemic, leading to a deteriorating environment," Fitch said modestly to 74% in 2020 and averaging 75% from 201
Years of competitive pricing and ongoing increases of judgments from several million dollars and demands for conciliation as well as growing defense-related costs have negatively affected insurance results , says Fitch …
From 2017 to 2020, D&O reported an average direct value average of 107%.
Acceleration in interest rate increases also reflects changes in risk appetite of many D&O insurance companies, with shifts in coverage terms and policy limits, which makes it more difficult to place larger programs, Fitch said.
Willis Towers Watson PLC project increases in the primary public company D&O to continue to increase by 10% to 40% in 2021, but surpluses may move even higher by 15% to 65%, the reports say.
Pandemic-related D&O losses are likely to take several years to fully measure and resolve, says Fitch.
Allegations can arise for leadership of companies that are experiencing shareholder value declines or insol. from the economic downturn of the pandemic, Fitch said. Allegations can also be made against organizations that have failed to protect employees or customers from exposure to the virus or serious illness.
Companies that create protective products or vaccines to prevent the virus or treatments that prove to be ineffective are also facing new D&O exposures, the report said.
More insurance and risk management news about the coronavirus crisis here .